EverGlade Leaders Appointed to BioMaP and MCDC to Enhance Health Security Collaboration
Recent Appointments at EverGlade
In a significant move to fortify the intersection between industry and government in the health sector, EverGlade has announced the appointments of Stephen Richardson and Laura (Powell) Grace, PhD, to influential leadership roles within two notable consortia. These roles will enable them to better advocate for the interests of members in the life sciences and technology sectors while enhancing national health security efforts.
Strategic Leadership Roles
Stephen Richardson, serving as the Head of Strategic Partnerships at EverGlade, has been designated as Chair for Voice of Membership on the Executive Steering Committee of the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP). Concurrently, Laura Grace has been appointed as a Small Business Representative on the Executive Committee of the Medical CBRN Defense Consortium (MCDC). These roles are vital as they bridge the existing gap between the government entities and health innovators, facilitating a proactive dialogue aimed at preparedness and response strategies.
BioMaP's Mission and Activities
BioMaP plays a crucial role in enhancing the nation’s biopharmaceutical manufacturing preparedness. The consortium is focused on ensuring resilience within the domestic supply chain and fostering collaboration between various stakeholders in government and the biopharmaceutical industry. In his role, Richardson emphasizes the importance of member feedback, showcasing his commitment to amplifying the voices and concerns of his colleagues in the industry.
“I appreciate the members' confidence in me,” Richardson stated. “BioMaP's strength lies in the expertise of its members. My goal is to listen to their insights and concerns, enhancing how they interact with consortium leadership and governmental bodies to ensure their perspectives inform BioMaP’s planning and initiatives.”
Through his leadership, Richardson hopes to strengthen the preparedness of the biomanufacturing sector, which has never been more critical in today's health climate.
Representing Small Businesses in Medical Defense
On a complementary note, Laura Grace will leverage her extensive knowledge and experience to represent small businesses at MCDC. Her role is to bring essential insights regarding the priorities and practical challenges small companies face in accessing and utilizing MCDC funding for medical countermeasure development against chemical, biological, radiological, and nuclear (CBRN) threats.
“Small businesses contribute vital innovation and capabilities to the field of medical countermeasures,” Grace noted. “My priority will be to ensure that the unique challenges faced by these companies are thoroughly represented in committee discussions, promoting productive dialogue between industry and the government.”
Grace’s position is pivotal for maintaining the momentum of promising programs that seek to protect national health security, emphasizing the necessity for effective collaboration.
Looking Forward: Enhancing Collaboration
The appointments of Richardson and Grace reflect EverGlade's overarching mission of linking innovators to the right federal resources. By fostering connections between industry leaders and government officials, they aim to streamline the funding process and enhance the outcomes of various health security initiatives.
In a statement from CEO Giacomo Apadula, he expressed pride in having his team members take on critical roles, stating, “Stephen and Laura will significantly influence the direction of consortium priorities, strengthen partnerships between industry and government, and ultimately improve program outcomes for our members.”
As they embark on this new journey, both leaders are positioned to champion the interests of their respective sectors, ensuring that innovation and collaboration remain at the forefront of national health security efforts.
About EverGlade
EverGlade specializes in navigating the federal funding landscape for life sciences and technology innovators. The firm offers comprehensive support throughout the funding lifecycle, from formulating technical strategies and developing proposals to negotiating contracts and managing post-award execution.
For more information on EverGlade and their initiatives, you can visit their official website.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.